Purple Book reference family · 351(a) biologic
acellular nerve allograft-arwx (avance nerve graft)
acellular nerve allograft-arwx is an FDA-licensed reference biologic from Axogen Corporation.
351(a) biologicBLA 125816 Axogen Corporation
Biosimilars
0
Interchangeables
0
Listed patents
0
Reference approved
2025
Reference product
Originator biologic
351(a)BLA 125816
avance nerve graft acellular nerve allograft-arwx
Axogen Corporation
View full reference-product record- Approved
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Protection horizon
Reference approval
Approval date of the reference acellular nerve allograft-arwx product.
8 mo ago
acellular nerve allograft-arwx: frequently asked questions
Reference exclusivity, biosimilars, interchangeability, and patents for this molecule, from the FDA Purple Book.
Built from official FDA Purple Book records (monthly downloads, the Advanced Search interface, and the published Patent List), with reference-product, license-type, and exclusivity context for acellular nerve allograft-arwx.
Related FDA reference tools
- FDA Orange BookApproved drugs, generics, therapeutic-equivalence codes, patents, and exclusivity.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
